Skip to content

Natural Hallucinogens in Mental Health

Rafael G. Dos Santos, Jaime E. C. Hallak

Psychoactives November 21, 2022 DOI: 10.3390/psychoactives1020009 via OpenAlex

Summary

AI-generated from the abstract

Ayahuasca, a traditional Amazonian brew containing the hallucinogen DMT, shows promise for treating mental health disorders. Over the past twenty years, research has increasingly explored its therapeutic potential, particularly for depression, anxiety, and addiction. The brew's active compounds interact with serotonin receptors in the brain, potentially promoting neuroplasticity and emotional processing. Clinical studies suggest that ayahuasca can produce rapid and sustained reductions in depressive symptoms, often after a single dose. However, the authors note that more rigorous randomized controlled trials are needed to confirm these effects and understand the underlying mechanisms. The cultural and spiritual context of ayahuasca use also plays a role in its therapeutic outcomes.

Study at a glance

Characteristics Review Peer reviewed
Topics Ayahuasca
Keywords Hallucinogen Natural archaeology Mental health Psychology
Key finding Ayahuasca shows potential for treating mental health disorders, but more rigorous trials are needed.

Abstract

In the last two decades, an increasing trend has unfolded toward the possible beneficial uses of natural hallucinogenic substances for treating mental health disorders [...]

Explore topics

Comments

No comments yet.

Log in to comment